Psoriasis Incidence in the United States Remains Steady
FRIDAY, April 23, 2021 -- Psoriasis incidence in the United States is steady, but increases with age and is higher among Whites, according to a study published in the April issue of the Journal of the American Academy of Dermatology.
Joshua Burshtein, from the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in New Hyde Park, New York, and colleagues used electronic medical records from 2,152,192 individuals (2014 to 2018) to estimate the incidence of psoriasis in the United States.
The researchers found that the incidence rate in the overall population was 63.8 per 100,000 person-years. There was increased incidence seen with age, with a peak among individuals aged 70 to 79 years (92.3 per 100,000 person-years). Men and women had a similar incidence (62.8 and 64.8 per 100,000 person-years, respectively). Rates were higher for Whites (75.3 per 100,000 person-years) than for Hispanic/Latinos (52.2 per 100,000 person-years) and Blacks (24.9 per 100,000 person-years). The incidence was stable during the five-year period.
"The current analysis is strengthened by inclusion of a large, demographically heterogeneous patient population, which enabled estimation of incidence across patient subgroups," the authors write.
One author disclosed financial ties to the pharmaceutical industry.
© 2021 HealthDay. All rights reserved.
Posted: April 2021
Read this next
TUESDAY, April 27, 2021 -- Patient characteristics at onset can help to estimate the long-term course of psoriasis with good discriminatory power, according to a study published...
MONDAY, April 26, 2021 -- For patients with moderate-to-severe plaque psoriasis, bimekizumab is noninferior and superior to secukinumab and adalimumab, according to two studies...
MONDAY, March 29, 2021 -- Psoriasis is associated with an increased risk for thyroid disease among U.S. adults, according to research published online March 16 in the Journal of...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.